Cargando…
Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. The prognosis for patients with high-grade and metastatic disease is still very poor, and survivors are burdened with long-lasting side effects. Therefore, more effective and less toxic therapies are needed. Surface proteins...
Autores principales: | Timpanaro, Andrea, Piccand, Caroline, Uldry, Anne-Christine, Bode, Peter Karl, Dzhumashev, Dzhangar, Sala, Rita, Heller, Manfred, Rössler, Jochen, Bernasconi, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917031/ https://www.ncbi.nlm.nih.gov/pubmed/36768928 http://dx.doi.org/10.3390/ijms24032601 |
Ejemplares similares
-
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
por: Timpanaro, Andrea, et al.
Publicado: (2023) -
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma
por: Dzhumashev, Dzhangar, et al.
Publicado: (2022) -
Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma
por: Alijaj, Nagjie, et al.
Publicado: (2020) -
The interplay between NCAM and FGFR signalling underlies ovarian cancer progression
por: Colombo, N, et al.
Publicado: (2011) -
Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion
por: Lavoie, Roxane R., et al.
Publicado: (2021)